News | Focused Ultrasound Therapy | May 07, 2020

Focused Ultrasound Opening Brain to Previously Impossible Treatments

Richard J. Price, Ph.D., of the University of Virginia's School of Medicine and School of Engineering, is using focused soundwaves to overcome the natural 'blood-brain barrier,' which protects the brain from harmful pathogens. Photo courtesy of Dan Addison | UVA Communications

Richard J. Price, Ph.D., of the University of Virginia's School of Medicine and School of Engineering, is using focused soundwaves to overcome the natural 'blood-brain barrier,' which protects the brain from harmful pathogens. Photo courtesy of Dan Addison | UVA Communications

May 7, 2020 — University of Virginia researchers are pioneering the use of focused ultrasound to defy the brain's protective barrier so that doctors could, at last, deliver many treatments directly into the brain to battle neurological diseases. The approach, the researchers hope, could revolutionize treatment for conditions from Alzheimer's to epilepsy to brain tumors - and even help repair the devastating damage caused by stroke.

Richard J. Price, Ph.D., of UVA's School of Medicine and School of Engineering, is using focused soundwaves to overcome the natural "blood-brain barrier," which protects the brain from harmful pathogens. His approach aims to breach the barrier only where needed, and only when needed, and then deliver treatments in exquisitely precise fashion.

"The blood-brain barrier is one of the greatest, if not the greatest, challenge to drug delivery for the central nervous system," Price explained. "Evolution gave us this barrier because the central nervous system needs to be protected. The problem is now we want to deliver something to those cells and evolution has had millions and millions of years to optimize a solution to stop it. ... So I'm attempting to circumvent biology with physics."

Focused Ultrasound's Great Potential

Focused ultrasound focuses sound waves inside the brain much like a magnifying glass can focus light, letting doctors manipulate tissue without cutting into the skull. Magnetic resonance imaging (MRI), meanwhile, lets them watch what's happening inside the brain in real time. While Price, a biomedical engineer, is developing his techniques in the lab, doctors are already using the technology to treat conditions such as Parkinson's tremor.

Price marvels at the approach's specificity. "With MRI, we can look at the target, whether it's a brain tumor or maybe it's a part of the brain we want to do gene therapy on, and we can select it — we can actually make a treatment plan and say, We only want to open the [blood-brain] barrier there. The other 95% of the brain, we don't even touch," said Price, the research director at UVA's Focused Ultrasound Center. "Then, when we apply the focused ultrasound, it opens the barrier there for a few hours. It lets us get the gene therapy across, and then it closes naturally."

Delivering Gene Therapy

Gene therapy introduced via focused ultrasound would essentially reprogram faulty cells.

For brain tumors, Price is exploring the potential of using focused ultrasound to deliver gene therapy via "deep-penetrating nanoparticles." The nanoparticles, designed by Price's collaborators at Johns Hopkins University, "are specifically engineered to penetrate the tissue extremely well," he said. The problem has been transporting them where they're needed, often deep inside the brain, and Price says focused ultrasound holds the answer.

His solution is to use the focused soundwaves to open spaces between cells in the tissue. "It doesn't help us if you can't get to the neuron that's 50 microns away," he said. "So that becomes an engineering transport problem."

In addition to delivering the therapy, focused ultrasound can "precondition" targeted tissue to enhance the effectiveness of the gene delivery up to five-fold, Price has found. The preconditioning represents a "simple and effective strategy" to boost the benefits of the nanoparticles, he and his colleagues report in a scientific paper.

Improving Stroke Outcomes

For stroke, a condition that is often debilitating when it's not deadly, Price aims to help the brain heal itself. He would do this by using focused ultrasound to put "homing molecules" inside damaged areas to recruit neural stem cells to do repairs. For this, his team has developed an innovative technique called "sonoselective transfection" that avoids opening the blood-brain barriers in brains that are already compromised.

"With stroke, there's a lot of effort to try to salvage as much neural tissue as possible by doing things like gene therapy," he said. "In our lab, we thought, well, maybe we can deliver treatment right to the cells that need it, without breaching the blood-brain barrier. And my students basically figured out how to do that."

That notion of helping the body heal itself, of using focused ultrasound to activate an immune response, could be useful in cancer treatments as well. "We would love to be able to put something into those [tumor] cells that will then allow them to start recruiting immune cells into the tumor," he said. "We have a lot of evidence that we can we can do some interesting things with focused ultrasound with respect to the internal landscape of those tumors."

Price, of UVA's Department of Biomedical Engineering, emphasizes that his work is still early, but he is excited to be creating new techniques that could change how many major diseases are treated in the not-too-distant future.

"We've had good results [with the research] so far. But what I, as an engineer, get excited about are all these tools we have made," he said. "You can use these tools for all these different applications. We think there are a lot of really exciting possibilities."

For more information: www.healthsystem.virginia.edu/home

Related Content

64-Year-Old Man With Clear Cell Likelihood Score (ccLS) 5 Renal Masses

64-Year-Old Man With Clear Cell Likelihood Score (ccLS) 5 Renal Masses. Coronal T2-weighted single shot fast spin echo and coronal T1-weighted fat-saturated spoiled gradient echo acquired during corticomedullary phase—ccLS5 lesion outlined red for clarity.

News | Magnetic Resonance Imaging (MRI) | July 22, 2021
Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly and Annual Meeting, the world’s largest annual radiology forum, to be held at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | July 21, 2021
July 21, 2021 — Registration is now open for the Radiological Society of North America (...
According to ARRS’ American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) substantially reduces the recall rate, while being unlikely to result in adverse outcome

Normal right mediolateral oblique (A) and craniocarudal (B) view screening mammograms demonstrate density C breasts. Coronal (C), transverse (D), and reconstructed lateral (E) views from supplemental automatic breast ultrasound (ABUS) demonstrates 7 mm circumscribed slightly hypoechoic circumscribed lesion at 11 o’clock position in right breast. Lesion was classified as BI-RADS 3. Patient has undergone yearly mammograms for 4 years following the ABUS examination with no breast cancer diagnosis.

News | Breast Imaging | July 16, 2021
July 16, 2021 —...
Ramon Alfredo Siochi, Ph.D. — the director of medical physics at WVU — led a task group to help ensure the accuracy of data that dictates a cancer patient's radiation therapy.

Ramon Alfredo Siochi, director of medical physics at West Virginia University. Image courtesy of WVU Photo/Aira Burkhart

News | Radiation Oncology | July 15, 2021
July 15, 2021 — Just as helicopter traffic reporters use their "bird's eye view" to route drivers around roadblocks s
Interviews with the 1,000 at-risk patients also led to some interesting conclusions, Fine said. Even in the early days of 3D mammography, most women interviewed had at least heard about the technology.

Getty Images

News | Mammography | July 15, 2021
July 15, 2021 —  For any type of diagnostic test, technology that helps improve the reliability of test results is a
ujifilm's robust medical systems portfolio includes a comprehensive product lineup covering CT, MRI, fluoroscopy, digital radiography, women’s health, ultrasound, systems integration, endoscopy and endosurgery, enterprise imaging, assisted reproductive technology, cell culture media, cell therapy development, In-Vitro diagnostics (IVD), and investigational drug development
News | Radiology Imaging | July 14, 2021
July 14, 2021 — Fujifilm announced the launch of the ...
In a mouse model study of MRI-guided focused ultrasound-induced blood-brain barrier (BBB) opening at MRI field strengths ranging from ­approximately 0 T (outside the magnetic field) to 4.7 T, the static magnetic field dampened the detected microbubble cavitation signal and decreased the BBB opening volum

In a mouse model study of MRI-guided focused ultrasound-induced blood-brain barrier (BBB) opening at MRI field strengths ranging from ­approximately 0 T (outside the magnetic field) to 4.7 T, the static magnetic field dampened the detected microbubble cavitation signal and decreased the BBB opening volume. Image courtesy of Washington University in St. Louis

News | Magnetic Resonance Imaging (MRI) | July 13, 2021
July 13, 2021 — ...